Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Editorial

Vol. 8 No. 2 (2005)

Impacting the Practice of Medicine by Industry

  • Steven Lin, BMSc
DOI
https://doi.org/10.26443/mjm.v8i2.666
Submitted
November 8, 2020
Published
2020-12-01

Abstract

N/A

References

  1. Conrad P, Leiter V. Medicalization, markets and consumers. J Health Soc Behav 45 Suppl:158-76; 2004.
  2. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Available at: http://www.fda.gov/cder/guidance/1804fnl.htm. Accessibility verified June 1, 2005.
  3. Rosenthal MB, Berndt ER, Donohue JM, et al. Promotion of prescription drugs to consumers. N Engl J Med 346(7):498-505; 2002.
  4. The Washington Post. Drug Ads Hyping Anxiety Make Some Uneasy. Available at: http://www.washingtonpost.com/ac2/wpdyn?pagename=article&node=&contentId=A1208-2001Jul15. Accessibility verified June 1, 2005.
  5. Lipsky MS, Taylor CA. The Opinions and Experiences of Family Physicians Regarding Direct-to-Consumer Advertising. J Fam Pract 45(6):495-9; 1997.
  6. Kuehn BM. Pharmaceutical industry funding for residencies sparks controversy. JAMA 293(13):1572-80; 2005.

Downloads

Download data is not yet available.

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.